Skip to main content
NASDAQ:IDXG

Interpace Biosciences News Headlines

Notice: This company has been marked as potentially delisted and may not be actively trading.
$8.00
0.00 (0.00 %)
(As of 05/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.48
$8.22
50-Day Range
$3.00
$7.73
52-Week Range
$2.57
$8.50
Volume13,188 shs
Average Volume178,906 shs
Market Capitalization$32.83 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23

Headlines

Interpace Biosciences (NASDAQ IDXG) News Headlines Today

SourceHeadline
Interpace Biosciences Announces First Quarter 2021 Financial and Business ResultsInterpace Biosciences Announces First Quarter 2021 Financial and Business Results
finance.yahoo.com - May 11 at 7:06 PM
Interpace Biosciences Announces Improved Coverage for ThyGeNEXT® and ThyraMIR®Interpace Biosciences Announces Improved Coverage for ThyGeNEXT® and ThyraMIR®
finance.yahoo.com - May 3 at 1:00 PM
BRIEF-Interpace Biosciences To Explore Strategic Alternatives For Maximizing Shareholder ValueBRIEF-Interpace Biosciences To Explore Strategic Alternatives For Maximizing Shareholder Value
msn.com - April 22 at 2:36 PM
Interpace Biosciences Considering Strategic, Financial And Operational Alternatives - Quick FactsInterpace Biosciences Considering Strategic, Financial And Operational Alternatives - Quick Facts
markets.businessinsider.com - April 22 at 9:36 AM
Interpace Biosciences to Explore Strategic Alternatives for Maximizing Shareholder ValueInterpace Biosciences to Explore Strategic Alternatives for Maximizing Shareholder Value
finance.yahoo.com - April 22 at 9:36 AM
Interpace Biosciences Raises Full Year 2021 Revenue GuidanceInterpace Biosciences Raises Full Year 2021 Revenue Guidance
finance.yahoo.com - April 19 at 9:00 AM
Interpace Pharma Solutions Announces New Advanced Offering in RNA Biomarker AnalysisInterpace Pharma Solutions Announces New Advanced Offering in RNA Biomarker Analysis
finance.yahoo.com - April 12 at 8:55 AM
Interpace Biosciences Announces New PLA Code and Medicare Reimbursement Increase for Proprietary Thyroid Assay, ThyGeNEXT®Interpace Biosciences Announces New PLA Code and Medicare Reimbursement Increase for Proprietary Thyroid Assay, ThyGeNEXT®
finance.yahoo.com - April 5 at 5:12 PM
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business ResultsInterpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results
finance.yahoo.com - March 31 at 10:25 PM
Interpace Biosciences to divest new haven CLIA lab to DiamirInterpace Biosciences to divest new haven CLIA lab to Diamir
seekingalpha.com - March 19 at 9:28 AM
Interpace Biosciences Announces Divestiture of New Haven CLIA lab to DiamiRInterpace Biosciences Announces Divestiture of New Haven CLIA lab to DiamiR
finance.yahoo.com - March 17 at 7:51 AM
Interpace Biosciences and XIFIN Forge Strategic Partnership to Improve Financial PerformanceInterpace Biosciences and XIFIN Forge Strategic Partnership to Improve Financial Performance
finance.yahoo.com - March 9 at 1:17 PM
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of IllinoisInterpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Illinois
finance.yahoo.com - February 25 at 6:14 PM
Interpace Biosciences Announces Acceptance for Trading on the OTCQXInterpace Biosciences Announces Acceptance for Trading on the OTCQX
finance.yahoo.com - February 24 at 8:45 PM
Interpace Biosciences Announces CFO Leadership TransitionInterpace Biosciences Announces CFO Leadership Transition
finance.yahoo.com - February 4 at 8:13 PM
Why Matinas BioPharmas Stock Is Trading Lower TodayWhy Matinas BioPharma's Stock Is Trading Lower Today
feeds.benzinga.com - February 1 at 1:02 PM
Interpace Biosciences Announces License Agreement with Rutgers University and Mass General HospitalInterpace Biosciences Announces License Agreement with Rutgers University and Mass General Hospital
finance.yahoo.com - February 1 at 12:45 PM
Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa®Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa®
benzinga.com - February 1 at 6:24 AM
Stock Alert: Interpace Biosciences Gain 15%Stock Alert: Interpace Biosciences Gain 15%
nasdaq.com - January 28 at 1:28 PM
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of FloridaInterpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Florida
finance.yahoo.com - January 28 at 1:28 PM
Interpace Biosciences, Inc. to Host Earnings CallInterpace Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - January 21 at 2:46 PM
Interpace Biosciences to Host Third Quarter 2020...Interpace Biosciences to Host Third Quarter 2020...
benzinga.com - January 20 at 8:47 PM
Interpace Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, January 21, 2021Interpace Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, January 21, 2021
finance.yahoo.com - January 20 at 3:47 PM
Interpace Biosciences Inc.Interpace Biosciences Inc.
barrons.com - December 3 at 9:32 PM
Interpace Biosciences Announces Executive Transition: Jack Stover to Retire as President and Chief Executive Officer Thomas Burnell Appointed as SuccessorInterpace Biosciences Announces Executive Transition: Jack Stover to Retire as President and Chief Executive Officer Thomas Burnell Appointed as Successor
finance.yahoo.com - November 25 at 9:25 AM
Interpace Biosciences delays 10-Q filingInterpace Biosciences delays 10-Q filing
seekingalpha.com - November 18 at 12:42 PM
Avanti Financial Joins Kraken as a Wyoming-Approved Crypto BankAvanti Financial Joins Kraken as a Wyoming-Approved Crypto Bank
coindesk.com - October 28 at 8:31 PM
Interpace Biosciences up 12% on validation of thyroid testsInterpace Biosciences up 12% on validation of thyroid tests
seekingalpha.com - October 26 at 12:34 PM
Interpace Biosciences Announces Results of Seminal Clinical Validation Study for Thyroid AssaysInterpace Biosciences Announces Results of Seminal Clinical Validation Study for Thyroid Assays
finance.yahoo.com - October 26 at 7:34 AM
PDI: An Attractive 10.70% Yield, Recent Dip Creates An OpportunityPDI: An Attractive 10.70% Yield, Recent Dip Creates An Opportunity
seekingalpha.com - October 21 at 7:15 AM
Interpace Biosciences EPS misses by $0.32, misses on revenueInterpace Biosciences EPS misses by $0.32, misses on revenue
seekingalpha.com - October 20 at 9:59 AM
Interpace Biosciences Announces Second Quarter 2020 Financial and Business ResultsInterpace Biosciences Announces Second Quarter 2020 Financial and Business Results
finance.yahoo.com - October 20 at 9:59 AM
Why Interpace Biosciences Is Trading Higher TodayWhy Interpace Biosciences Is Trading Higher Today
benzinga.com - October 15 at 12:31 AM
Interpace Bio prevails in fallacious employee complaints; shares +67%Interpace Bio prevails in fallacious employee complaints; shares +67%
seekingalpha.com - October 14 at 2:30 PM
Stock Alert: Interpace Biosciences Gains 45% On Positive Audit ReportStock Alert: Interpace Biosciences Gains 45% On Positive Audit Report
nasdaq.com - October 14 at 2:30 PM
Interpace receives deficiency notice from Nasdaq over delayed filingInterpace receives deficiency notice from Nasdaq over delayed filing
seekingalpha.com - August 20 at 12:16 PM
Interpace Biosciences Receives Nasdaq Deficiency Notice Due to Delayed Filing of Form 10-Q; No Immediate Impact on ListingInterpace Biosciences Receives Nasdaq Deficiency Notice Due to Delayed Filing of Form 10-Q; No Immediate Impact on Listing
finance.yahoo.com - August 20 at 12:16 PM
BUZZ-U.S. STOCKS ON THE MOVE-Interpace Biosciences, Overstock, Unity BiotechnologyBUZZ-U.S. STOCKS ON THE MOVE-Interpace Biosciences, Overstock, Unity Biotechnology
nasdaq.com - August 19 at 1:35 PM
Clovis Rubraca Data, And Other News: The Good, Bad And Ugly Of BiopharmaClovis Rubraca Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - August 18 at 12:29 PM
Interpace Biosciences down 26% on potential compliance issuesInterpace Biosciences down 26% on potential compliance issues
seekingalpha.com - August 17 at 3:16 PM
Interpace Announces Acceptance of Seminal Clinical Validation Study for Thyroid AssaysInterpace Announces Acceptance of Seminal Clinical Validation Study for Thyroid Assays
finance.yahoo.com - July 21 at 7:22 AM
NUS, CPST, SOLO and MEIP among midday moversNUS, CPST, SOLO and MEIP among midday movers
seekingalpha.com - July 2 at 12:52 PM
Interpace Q1 revenue +53%, shares -7.5%Interpace Q1 revenue +53%, shares -7.5%
seekingalpha.com - June 26 at 1:16 PM
Edited Transcript of IDXG earnings conference call or presentation 25-Jun-20 8:30pm GMTEdited Transcript of IDXG earnings conference call or presentation 25-Jun-20 8:30pm GMT
finance.yahoo.com - June 26 at 8:15 AM
Interpace Biosciences, Inc. (IDXG) CEO Jack Stover on Q1 2020 Results - Earnings Call TranscriptInterpace Biosciences, Inc. (IDXG) CEO Jack Stover on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - June 25 at 10:13 PM
Interpace Biosciences EPS misses by $1.07, beats on revenueInterpace Biosciences EPS misses by $1.07, beats on revenue
seekingalpha.com - June 25 at 5:12 PM
Interpace Biosciences Announces First Quarter 2020 Financial and Business ResultsInterpace Biosciences Announces First Quarter 2020 Financial and Business Results
finance.yahoo.com - June 25 at 5:12 PM
Interpace Biosciences to Host Conference Call and Webcast to Discuss First Quarter, 2020 Financial Results on Thursday June 25, 2020Interpace Biosciences to Host Conference Call and Webcast to Discuss First Quarter, 2020 Financial Results on Thursday June 25, 2020
finance.yahoo.com - June 24 at 5:58 PM
Banks at risk of needing to cut dividends after Fed stress testsBanks at risk of needing to cut dividends after Fed stress tests
feeds.marketwatch.com - May 27 at 1:38 PM
PDI: I Cant Get Excited At A 10% PremiumPDI: I Can't Get Excited At A 10% Premium
seekingalpha.com - May 25 at 3:28 AM
This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.